NCT02607163View on ClinicalTrials.gov

The Effect of Dexmedetomidine on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery

NACompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 6, 2019

Study Completion Date

March 6, 2019

Conditions
Acute Kidney Injury(Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery)
Interventions
DRUG

dexmedetomidine

Immediately after the induction of anesthesia, patients in the dexmedetomidine group received dexmedetomidine continuous intravenous (IV) infusion of 0.4 mcg/kg/h until 24 hours after surgery.

DRUG

saline

same infusion rate (received equal volume of normal saline), IV, The infusion of study drug is started after anesthesia induction and continued until 24 hours after surgery.

Trial Locations (1)

03722

Department of Anesthesiology and Pain Medicine, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT02607163 - The Effect of Dexmedetomidine on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery | Biotech Hunter | Biotech Hunter